
IndraLab
Statements
Hydroxychloroquine activates Disease. 6 / 6
|
4
2
reach
"Systematic reviews of randomized controlled and observational studies of antimalarial drugs in SLE strongly support the immunomodulatory capacity of HCQ, including the ability to prevent disease flares, promote long-term survival, and control disease activity during pregnancies without evidence of fetotoxic or embryotoxic effects (76, 77)."